HELSINKI Oct 21 Finnish drug maker Orion
reported a 12 percent fall in third-quarter operating
profit on Tuesday due to increased price competition following
the expiration of its Parkinson's drug patents.
Orion reported a quarterly operating profit of 67 million
euros ($91.6 million), down from 76 million euros a year earlier
and in line with the market's average forecast.
Quarterly sales fell 4 percent from a year earlier to 237
million euros, below an expected 245 million euros.
($1 = 0.7312 euros)
(Reporting by Ritsuko Ando, Editing by Patrick Lannin)